AZD6140
AZD6140 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
Uric Acid Study in Healthy Male Volunteers
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers
Clinical Trials (6)
Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
Uric Acid Study in Healthy Male Volunteers
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers
AZD6140 Oral Contraceptive Interaction Study
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6